×

Biotech and Pharmaceuticals Pharmaceuticals

  • LONDON, June 20- GlaxoSmithKline is taking its fight with Gilead Sciences for dominance of the HIV market to the world's leading AIDS conference next month by showcasing detailed results from its new two-drug treatment. Deborah Waterhouse, head of GSK's majority-owned HIV business ViiV Healthcare, aims to overtake Gilead as market leader in the $26 billion-...

  • TOKYO, June 20- Japan's Nikkei share average rose in volatile trade on Wednesday, helped by late short-covering following an earlier selloff and a broader recovery in regional sentiment as Chinese shares recovered from a rout in the previous session. Like other markets, Tokyo- listed stocks were knocked heavily on Tuesday as the tit-for-tat trade dispute...

  • *Top Roche scientist to head R&D from July 1. PARIS, June 20- Sanofi missed the boat on immune system-boosting cancer drugs. The French drugmaker has hired John Reed, the former top scientist at oncology market leader Roche to head its group research operations.

  • *Markets braced for July trade talks between Japan and U.S. TOKYO, June 20- Japan's Nikkei share average was flat in choppy trade on Wednesday morning as firms that rely on China demand tumbled on trade war worries, with machine tool makers and shippers posting multi-month lows, which offset gains in defensive stocks. Machine tool makers led the losses, with Okuma...

  • Medical device maker Optinose's CEO touts 'innovative' approach to building awareness

    Jim Cramer hears from Optinose CEO Peter Miller, who shares the latest on his ear, nose and throat medical device company.

  • Jim Cramer on "Mad Money."

    Jim Cramer says there are a lot of things that scare him about a U.S.-China trade war, but selling its position in U.S. Treasurys isn’t one of them.

  • Gene therapy trial in muscular dystrophy patients shows exciting results

    Doug Ingram, Sarepta CEO, talks about the positive outcomes of a muscular dystrophy trial on three kids.

  • June 19- Sarepta Therapeutics Inc shares jumped 60 percent on Tuesday after the drugmaker reported promising results from an early-stage study testing its gene therapy in patients with Duchenne muscular dystrophy. "I have been waiting my entire 49- year career to find a therapy that dramatically reduces CK levels and creates significant levels of...

  • A CVS Pharmacy store is seen in the Manhattan borough of New York City, New York, U.S., November 30, 2017.

    CVS' move will be a test of whether patients are willing to wait for their medicines in exchange for convenience.

  • PARIS, June 19- French drugmaker Sanofi announced it had hired Jean-Baptiste Chasseloup de Chatillon, the former chief financial officer at carmaker and Peugeot-manufacturer PSA who had helped oversee a revival in PSA's fortunes. "Jean-Baptiste is an experienced CFO who has been part of the impressive turnaround of PSA Group," said Sanofi chief executive...

  • PARIS, June 19- French drugmaker Sanofi announced it had hired Jean-Baptiste Chasseloup de Chatillon, the former chief financial officer at carmaker and Peugeot-manufacturer PSA, to take up a similar position within Sanofi. Sanofi said Chasseloup de Chatillon would become its executive vice-president and chief financial officer, with his position taking...

  • Elizabeth Holmes founder of Theranos

    Proving that Elizabeth Holmes and former Theranos President Ramesh Balwani were lying to investors, and not just deluded about her ability to disrupt the health-care industry, won’t be an easy task for prosecutors, the New York Times reports.

  • Michel Vounatsos

    Biogen tumbled 6 percent on Monday, after a rival reported its experimental drug for spinal muscular atrophy helped a majority of babies who received it.

  • NEW YORK— U.S. stocks shrugged off early losses and wound up with a mixed finish Monday. Household goods companies took some of the worst losses as the S&P 500 index fell for the third time in four days. That came after indexes in Europe and Asia fell.

  • Painkiller overdoses are killing 116 people, every day. CNBC's "On the Money" asks the co-director of the Johns Hopkins Center for Drug Safety what needs to be done to reverse this growing public health threat.

  • TOKYO, June 15- Japan's Nikkei share average rose on Friday after the European Central Bank announced it would avoid raising rates until mid-2019, but chip-related stocks tumbled as a brokerage slashed the target price of Tokyo Electron. "Investors were relieved that there is no imminent tightening in Europe, the day after they were spooked by the U.S.

  • TOKYO, June 15- Japan's Nikkei share average rose on Friday morning after the European Central Bank announced it would avoid raising rates until mid-2019, but chip-related stocks tumbled after a brokerage slashed the target price of Tokyo Electron. "Investors were relieved that there is no imminent tightening in Europe, the day after they were spooked by the...

  • It's all about data for companies and sales: GSK executive

    Brian McNamara of GSK says the company's consumer health unit is committed to higher margins and the digital economy is an "enabler to that."

  • A pharmacy technician fills a prescription inside a Wal-Mart store in Trevose, Pa.

    Amid the battle over who benefits the most from increasing prescription drug prices, Eli Lilly CEO David Ricks says, "It's time for a change" to the system.

  • The lawsuit by Kentucky Attorney General Andy Beshear was his sixth to date seeking to hold corporations like drug manufacturers and distributors responsible for their roles in the drug abuse crisis. The only possible explanation for the large quantities of opioids dispensed from its Kentucky stores was that some of the drugs were distributed to addicts...